Illumina (ILMN) Rivals Could Catch a Cold From its Warning

Illumina's (Nasdaq: ILMN) nasty warning after the close could spell trouble for rivals. Shares of ILMN are down 20 percent after saying it sees Q3 sales of about $235 million, which compares to the Street estimate of $277.72 million. The company is also suspending guidance for the full year.

Rivals:
Affymetrix, Inc. (Nasdaq: AFFX)
Agilent Technologies, Inc. (NYSE: A)
Complete Genomics, Inc. (Nasdaq: GNOM)
Life Technologies Corporation (Nasdaq: LIFE)
Luminex Corporation (Nasdaq: LMNX)
Pacific Biosciences of California, Inc. (Nasdaq: PACB)
QIAGEN N.V. (Nasdaq: QGEN)
Sequenom, Inc., (Nasdaq: SQNM)

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Planet Green halted again, now up 793%
• Berkshire adds significantly to Alphabet position, starts small position in DR Horton